Browsing Tag
emiltatug ledadotin
2 posts
Day One Biopharmaceuticals moves to acquire Mersana Therapeutics in $285m cancer-drug deal
Find out how Day One Biopharmaceuticals’ $285 million acquisition of Mersana Therapeutics could reshape the rare-cancer ADC landscape today.
Mersana Therapeutics reports positive phase 1 data for novel ADC in triple-negative breast cancer
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical innovator, has announced promising early clinical data from its Phase 1 trial…